Nail manifestations in COVID recovered patients
Keywords:
Nail, COVID 19, PandemicAbstract
Objective The study was conducted to describe the nail changes among COVID 19 infection recovered patients.  Methods The study was done at tertiary care centre involving 90 patients who were recovered from COVID 19 infection. This was a cross sectional study conducted from July 2021 to June 2022 after obtaining institutional ethics committee clearance.  Results Out of 90 patients, about 58.8% of cases were in 21-30 age group, with equal proportion of males and females. Based on the post COVID duration, 44.4% of patients  presented within 2 months. The nail findings were present in 47% of patients (31 cases) in mild infection, 63.6% (14 cases) of moderate infection and 100% of severe infection (3 cases), although p-value was insignificant (>0.05).  Conclusion The changes occurring in the nail depicts the severity of disease and also tell about the complications and sequel associated with the disease. ÂReferences
Singh G. Nails in systemic disease. Indian J Dermatol Venereol Leprol 2011;77:646-651
Senturk N, Ozdemir H. Onychomadesis following COVIDâ€19 infection: Is there a relationship? Dermatol Ther. 2020;33:2–3.
Ocampo-Garza SS, Ocampo-Candiani J, Camela E, Vastarella M, Fabbrocini G, Scalvenzi M, Villani A. Nail changes as manifestation of systemic disease in COVID-19 infection. J Eur Acad Dermatol Venereol. 2021;35(8):e474-e475.
Ladozhskaya-Gapeenko ЕЕ, Khrapov КN, Polushin YS, Shlyk IV, Vartanova IV, Fionik ÐÐœ, Danilova DM. Evaluation of microcirculation disorders in patients with severe COVID-19 by nail bed capillaroscopy. Messenger of Anesthesiology and Resuscitation. 2021;18(1):27-36.
Grover C, Saha S, Pandhi D. Nail Changes in COVID-19: A Cross Sectional Study From India. Indian Dermatol Online J. 2022;13(3):326-33.
Hadeler E, Morrison BW, Tosti A. A review of nail findings associated with COVID-19 infection. J Eur Acad Dermatol Venereol. 2021;35(11):e699-e709.
Alobaida S, Lam JM. Beau lines associated with COVID-19. CMAJ. 2020;192(36):E1040.
Yaemsiri S, Hou N, Slining MM, He K. Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatol Venereol. 2010;24:420-3.
Alobaida S, Lam JM. Beau lines associated with COVID-19. CMAJ. 2020;192(36):E1040.
Ide S, Morioka S, Inada M, Ohmagari N. Beau's lines and leukonychia in a COVID-19 patient. Intern Med. 2020;59((24):3259.
Holzberg M, Piraccini BM. Nail in systemic diseases. In: Baran R, deBerker D, Holzberg M, Piraccini BM, Richert B, Thomas L, editors. Baran &Dawber's Diseases of the Nails and their Management. 5th ed. Oxford, UK: John Wiley &Sons Ltd; 2019. pp. 481–573.
Meyerson MS, Scher RK. Nail signs of systemic disease. In: Callen JP, Jorizzo JL, Greer KE, Penneys NS, Piette WW, Zone JJ, editors. Dermatological signs of internal disease. 2 nd ed. Philadelphia: WB Saunders Co.; 1999. p. 368-75.
Holzberg M, Walker HK. Terry's nails:Revised definition and new correlations. Lancet. 1984;1:896-9.
Daniel CR, Sams WM, Scher RK. Nails in systemic disease. Dermatol Clin. 1985;3:167-87.
Goodman GJ, Nicolopoulos J, Howard A. Diseases of the generative nail apparatus. Part II: Nail bed. Australas J Dermatol 2002;43:157-70.
